Advanced Medical Optics
From Wikipedia, the free encyclopedia
Advanced Medical Optics | |
Type | Public (NYSE: EYE) |
---|---|
Founded | Santa Ana, California (2002) |
Headquarters | Santa Ana, California |
Key people | James V. Mazzo Chairman, President and CEO |
Industry | Ophthalmology |
Products | Ophthalmic pharmaceuticals Surgical equipment Contact care products |
Employees | 3,800 (2007) |
Website | http://www.amo-inc.com/ |
Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO is based in Santa Ana, California, and employs approximately 3,800 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.
Contents |
[edit] History
AMO was spun off from Allergan in 2002.
[edit] Voluntary recall
AMO volunatrily recalled some of their products in 2006 due to a bacterial contamination in the factory process which would have compromised sterility. Non-sterility of a contact lens solution may have serious health consequences, including eye infection and microbial keratitis. The voluntary and limited recall was caused by an isolated production line problem that affected two of the four production lines in the AMO facility, not because of a formulation issue.
This happened in the midst of a recall scare period caused by Bausch & Lomb's worldwide product recall, after eye care doctors in Singapore traced 90% of their patients' eye infections, some to the serious extent of causing blindness, to B&L products. In actual fact, no reports of adverse health effects due to the suspected-affected batch of products were made to AMO.
AMO's immediate voluntary recall was applauded by many as a considerate act towards their product users, because they were seen as being more concerned about the potential effects of the contamination on their users rather than a risk of association with serious eye health problems after the initial recall scares.
In some countries, there were initial confusion between B&L's product dangers and AMO's voluntary recall.
[edit] Consumer products
[edit] All-in-one Systems for soft contact lenses
- COMPLETE® Blink-N-Clean® Lens Drops
- COMPLETE® Moisture PLUS™
- COMPLETE® Moisture PLUS™ 120ml+lens case
- COMPLETE® Moisture PLUS™ 24ml
- COMPLETE® Moisture PLUS™ 360ml+lens case
- COMPLETE® Moisture PLUS™ half Year packages
- COMPLETE® Moisture PLUS™ Duo Pack
- COMPLETE® Moisture PLUS™ lens case
[edit] Hydration Solutions
- Blink®™ Contacts 10ml
- Blink®™ Contacts 20*0.35ml
- Blink®™ Eyedrops 10ml
- Blink®™ Eyedrops 20*0.35ml
[edit] Systems for formstabile, permiable contact lenses
- Totalcare®™ All-in-One
- Totalcare®™ Solution
- Totalcare®™ Cleaner
- Totalcare®™ Tablets
- Totalcare®™ Lens case
[edit] Protein Removers
- Ultrazyme®™ Tablets
[edit] Peroxyde systems
- Oxysept 1 Step®™ 1 Month
- Oxysept 1 Step®™ 3 Months
- Oxysept 1 Step®™ 6 Months
- Oxysept 1 Step®™ Tablets
- Oxysept 1 Step®™ Lens case
[edit] Multipurpose Solutions
- COMPLETE® Moisture PLUS™ Lubricating and Rewetting Drops
[edit] Peroxide Systems
- UltraCare® Disinfecting Solution/Neutralizer
- Ultrazyme® Enzymatic Cleaner
[edit] Surgical Products
- Sovereign® system with WhiteStar™ technology, (performs phacoemulsification cataract surgery)
- Sovereign® Compact
[edit] External links
- Official website of AMO
- htpp://www.amo-eyecare-sea.com/ South East Asia website of AMO